Wednesday, November 11, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· July 28, 2026

After-Hours Earnings Report for July 28, 2026 : V, KLAC, STX, WM, MDLZ, NXPI, F, BE, TER, ACGL, EXR, FE

View original at nasdaq.com
After-Hours Earnings Report for July 28, 2026 : V, KLAC, STX, WM, MDLZ, NXPI, F, BE, TER, ACGL, EXR, FE The following companies are expected to report earnings after hours on 07/28/2026…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • NXP Semiconductors beat consensus EPS every quarter in the past year, with the largest beat of 0.38% in the 1st calendar quarter

    60% confidence
  • Bloom Energy beat consensus EPS every quarter in the past year, with the largest beat of 1400% in the 1st calendar quarter

    60% confidence
  • Waste Management's 2026 P/E ratio of 29.15 vs. industry ratio of 21.90 implies higher earnings growth than industry competitors

    60% confidence
  • Teradyne's 2026 P/E ratio of 46.50 vs. industry ratio of 14.50 implies higher earnings growth than industry competitors

    60% confidence
  • Arch Capital's 2026 P/E ratio of 11.12 vs. industry ratio of 9.90 implies higher earnings growth than industry competitors

    60% confidence
  • FirstEnergy's 2026 P/E ratio is 18.07 vs. an industry ratio of 19.20

    60% confidence
  • Visa's 2026 P/E ratio of 27.63 vs. industry ratio of 25.00 implies higher earnings growth than industry competitors

    60% confidence
  • Ford's 2026 P/E ratio is 9.06 vs. an industry ratio of 32.60

    60% confidence
  • Seagate's 2026 P/E ratio of 57.78 vs. industry ratio of 20.40 implies higher earnings growth than industry competitors

    60% confidence
  • Mondelez's 2026 P/E ratio of 19.96 vs. industry ratio of 2.70 implies higher earnings growth than industry competitors

    60% confidence
  • FirstEnergy met analyst expectations once and beat expectations the other three quarters in the past year

    60% confidence
  • Extra Space Storage's 2026 P/E ratio of 17.95 vs. industry ratio of 14.20 implies higher earnings growth than industry competitors

    60% confidence
  • Ford missed consensus EPS in the 4th calendar quarter of 2025 by -23.53%

    60% confidence
  • Arch Capital beat consensus EPS every quarter in the past year, with the largest beat of 2.04% in the 1st calendar quarter

    60% confidence
  • Visa beat consensus EPS every quarter in the past year, with the largest beat of 7.12% in the 1st calendar quarter

    60% confidence
  • NXP Semiconductors' 2026 P/E ratio is 19.89 vs. an industry ratio of 81.50

    60% confidence
  • Teradyne beat consensus EPS every quarter in the past year, with the largest beat of 21.33% in the 1st calendar quarter

    60% confidence
  • Seagate beat consensus EPS every quarter in the past year, with the largest beat of 20.25% in the 1st calendar quarter

    60% confidence
  • KLA met analyst expectations once and beat expectations the other three quarters in the past year

    60% confidence
  • KLA's 2026 P/E ratio of 54.81 vs. industry ratio of 14.50 implies higher earnings growth than industry competitors

    60% confidence
  • Mondelez beat consensus EPS every quarter in the past year, with the largest beat of 9.84% in the 1st calendar quarter

    60% confidence
  • Extra Space Storage missed consensus EPS in the 2nd calendar quarter of 2025 by -0.49%

    60% confidence
  • Bloom Energy's 2026 P/E ratio of 131.59 vs. industry ratio of 18.80 implies higher earnings growth than industry competitors

    60% confidence

Data points we hold from this source

Visa Inc. · eps3.23 USD
Visa Inc. · pe ratio27.63 ratio
Ford Motor Company · pe ratio9.06 ratio
Ford Motor Company · eps0.33 USD
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,564 source documents archived
Query this data → isubstrate.com
After-Hours Earnings Report for July 28, 2026 : V, KLAC, STX, WM, MDLZ, NXPI, F, BE, TER, ACGL, EXR, FE — Source | Via News | Via News